Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment

Clinical trial NCT07033182 · COMPLETED

Trial details

NCT number: NCT07033182
Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infections Caused by Anaerobic Bacteria Renal Impairment

Start date: 2023-10-30
Primary completion: 2024-04-07
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.